Gianluca Gaidano
Novara, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 435 publications
Association Between Socioeconomic Inequalities and Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma.
Journal: JCO oncology practice
Published: May 27, 2026
Molecular Mechanisms of Resistance to Bispecific Antibodies in Diffuse Large B-Cell Lymphoma.
Journal: Cells
Published: March 20, 2026
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: March 18, 2026
Ten-day decitabine vs "3+7" in patients with AML aged ≥60 years: long-term results of the randomized phase 3 EORTC trial AML21.
Journal: Blood neoplasia
Published: February 20, 2026
Consensus-based ranking of determinants for frontline therapy selection in chronic lymphocytic leukemia: A conjoint analysis.
Journal: Critical reviews in oncology/hematology
Published: January 20, 2026
Molecular Pathogenesis and Targeted Treatment of Richter Transformation.
Journal: Biomedicines
Published: December 31, 2025
Acalabrutinib in Chronic Lymphocytic Leukemia: Pharmacology and Emerging Clinical Perspectives.
Journal: European journal of haematology
Published: November 13, 2025
XPO-1 targeting in chronic lymphocytic leukemia: is there potential for therapeutic strategy?
Journal: Expert opinion on therapeutic targets
Published: November 12, 2025
Last Updated: 09/26/2026